Use of C-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with Metabolic Syndrome
, , , , , , , , , , y | 29 mar 2024
Acerca de este artículo
Article Category: Original Article
Publicado en línea: 29 mar 2024
Páginas: 24 - 30
DOI: https://doi.org/10.2478/rjc-2024-0003
Palabras clave
© 2024 Ylber Jani et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Results for maintenance of sinus rhythm and AF-Recurence in participans with MS (n.215) according to CRP levels
| Results for maintenance of sinus rhythm and AF-Recurrence Study Group(n-215). | |||||
|---|---|---|---|---|---|
| Participants with CRP >3.0mg/L (n.110) | Participants with CRP < 3.0mg/L(n.105) | Total(n.215) | |||
| Sinus Rhythm | AF-Recurrence | Sinus Rhythm | AF-Recurrence | P | |
| (No) | 35 | 75 | 68 | 37 | |
| (%) | 68.1 | 35.2 | |||
Logistic Rgression Model:Association of CRP levels (>3.0mg/L) with: AF-recurence, LAd, LAVI, LVMI and BMI
| OR* | Significance | 95% CI for Exp (B) | ||
|---|---|---|---|---|
| Lower | Upper | |||
| AF recurrence | 3.938 | .000 | 2.234 | 6.942 |
| LAd | 3.817 | .000 | 0.989 | 1.544 |
| LAVI | 1.74 | .000 | 1.549 | 1.975 |
| LVMI | 1.041 | .000 | 1.022 | 1.061 |
| BMI | 2.072 | .000 | 1.203 | 3.571 |
Baseline characteristics of patients with MS (n.215),according to CRP levels
| Variables | MS (N.215) | P - value | |||||
|---|---|---|---|---|---|---|---|
| Gr. with CRP levels ≥ 3mg/l (n-110) | Gr.with CRP levels < 3mg/l (n.105) | ||||||
| N. (%) | Mean | ±SD | N. (%) | Mean | ±SD | ||
| Gender. Females | 59(52) | 51(48,8) | 0.4 | ||||
| Age (year) | 58.8 | ±5.2 | 56.9 | ±5.4 | 0.5 | ||
| BMI(kg/m2) | 27.4 | ±6.5 | 25.0 | ±4.0 | |||
| AF(paroxysmal) | 62(56.3) | 58 (55.2) | 0.51 | ||||
| AF(persistens) | 48 (44.7) | 47 (44.8) | 0.50 | ||||
| CRP(mg/dL) | 8.4 | ±2.3 | 2.7 | ±0.1 | |||
| CAD-presence n(%) | 7(5.4) | 5(4.7) | 0.42 | ||||
| HF - presence n(%) | 9(8.1) | 6(5.7) | 0.34 | ||||
| RD - presence n(%) | 4(3.8) | 4(3.6) | 0.61 | ||||
| STROK-pres. n(%) | 10(9.5) | 9(8.5) | 0.54 | ||||
| LAd(cm/m2) | 4.1 | ±0.3 | 3.8 | ±0.2 | |||
| LAVI(mL/m2) | 30.6 | ±4.6 | 28.5 | ±4.3 | |||
| LVMI(g/m2) | 96.8 | ±1.1 | 66.8 | ±5.2 | |||
| ESD(cm) | 2.9 | ±0.4 | 2.73 | ±0.7 | 0.06 | ||
| EDD(cm) | 4.8 | ±0.5 | 4.8 | ±0.4 | 0.07 | ||
| THS(cm) | 1.2 | ±2.1 | 1.2 | ±1.5 | 0.06 | ||
| THPW(cm | 1.1 | ±0.5 | 1.1 | ±0.7 | 0.07 | ||
| EF(%) | 0.67 | ±0.7 | 0.66 | ±0.5 | 0.5 | ||